{
    "organizations": [],
    "uuid": "851748ab26952b7b02d7602721ba8c868da7de3b",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-ligand-prices-offering-of-650-mln/brief-ligand-prices-offering-of-650-mln-of-convertible-senior-notes-idUSASC0A2X0",
    "ord_in_thread": 0,
    "title": "BRIEF-Ligand Prices Offering Of $650 Mln Of Convertible Senior Notes",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 18 (Reuters) - Ligand Pharmaceuticals Inc:\n* LIGAND PRICES OFFERING OF $650 MILLION OF CONVERTIBLE SENIOR NOTES\n* LIGAND PHARMACEUTICALS INC - PRICING OF $650 MILLION AGGREGATE PRINCIPAL AMOUNT OF 0.75% CONVERTIBLE SENIOR NOTES DUE 2023\n* LIGAND PHARMACEUTICALS INC - CONVERSION RATE FOR NOTES WILL INITIALLY BE 4.0244 SHARES PER $1,000 PRINCIPAL AMOUNT OF NOTES Source text for Eikon: Further company coverage:\n ",
    "published": "2018-05-18T20:26:00.000+03:00",
    "crawled": "2018-05-19T15:11:40.000+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "ligand",
        "pharmaceutical",
        "inc",
        "ligand",
        "price",
        "offering",
        "million",
        "convertible",
        "senior",
        "note",
        "ligand",
        "pharmaceutical",
        "inc",
        "pricing",
        "million",
        "aggregate",
        "principal",
        "amount",
        "convertible",
        "senior",
        "note",
        "due",
        "ligand",
        "pharmaceutical",
        "inc",
        "conversion",
        "rate",
        "note",
        "initially",
        "share",
        "per",
        "principal",
        "amount",
        "note",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}